Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210034468 210008244 1.73 85 Curative (C) 2013-11-19 2014-06-02 UKALL 14 TRIAL Y null 210015019 UKALL2014
210034469 210008245 null 73.3 Curative (C) 2018-01-31 2018-07-16 UKALL14- Intens/CNS Proph Y N 210015020 UKALL2014
210034470 210008254 1.71 79 Disease modification (D) 2012-09-09 2013-10-04 UKALL14- Ph 2 Induction N N 210015041 UKALL2014
210034471 210019303 1.83 90.8 Curative (C) 2016-11-23 2017-03-08 UKALL14- Intens/CNS Proph null N 210015062 UKALL2014
210034472 210008264 1.74 73.9 Curative (C) 2014-05-04 2014-05-04 UKALL14- Maintenance + Imatinib null N 210015067 UKALL2014
210034473 210008267 1.58 55.3 Curative (C) 2014-03-15 2014-03-27 UKALL14- Intens/CNS Proph 01 N 210015070 UKALL2014
210034474 210008275 1.76 75.3 Curative (C) 2014-08-12 2014-08-12 UKALL14- Ph 1 Induction Y N 210015090 UKALL2014
210034475 210008276 1.67 null null 2014-03-17 2014-03-17 UKALL14- Ph 2 Induction + Imatinib N N 210015104 UKALL2014
210034476 210019309 1.89 62.9 Curative (C) null 2013-07-22 UKALL14- Ph 2 Induction N Y 210015114 UKALL2014
210034477 210008287 null 71 Curative (C) 2013-11-01 2014-02-06 UKALL14- Ph 2 Induction Y N 210015125 UKALL2014
210034478 210008288 1.68 71.8 Curative (C) 2015-03-24 2015-07-07 UKALL14- Ph 2 Induction N null 210015133 UKALL2014
210034479 210008294 1.62 60.9 Disease modification (D) 2014-06-05 2014-07-25 UKALL14- Ph 2 Induction N Y 210015141 UKALL2014
210034480 210008299 1.82 94.499 Palliative (P) 2019-01-05 2019-01-05 UKALL14- Ph 2 Induction Y N 210015173 UKALL2014
210034481 210019318 1.58 91.8 Curative (C) 2015-05-07 2015-05-07 UKALL14- Ph 2 Induction + Imatinib 02 N 210015192 UKALL2014
210034482 210008312 1.62 85 Curative (C) 2015-08-03 2015-10-06 UKALL14- Ph 2 Induction 01 N 210015202 UKALL2014
210034483 210008316 1.7 74.4 Curative (C) 2015-12-19 2015-12-24 UKALL14- Ph 2 Induction null N 210015206 UKALL2014
210034484 210008323 null 80.3 Palliative (P) 2016-04-04 2016-05-21 UKALL14- Ph 2 Induction null N 210015216 UKALL2014
210034485 210008330 null 57.7 Curative (C) 2014-11-19 2014-11-19 UKALL14- Maintenance Y 0 210015220 UKALL2014
210034486 210008336 1.51 91.8 Curative (C) 2015-04-18 2015-04-18 UKALL14- Ph 2 Induction Y N 210015224 UKALL2014
210034488 210008354 0 72 Curative (C) 2017-08-09 2018-05-12 UKALL14- Intens/CNS Proph N N 210015258 UKALL2014
210034489 210008359 null 65 Curative (C) 2015-01-31 2015-10-08 UKALL14- Intens/CNS Proph Y null 210015268 UKALL2014
210034490 210008366 1.89 81.1 Curative (C) null 2017-12-25 UKALL14- Intens/CNS Proph Y null 210015285 UKALL2014
210034491 210008373 1.83 60.5 Curative (C) 2015-08-13 2015-12-25 UKALL14- Intens/CNS Proph Y N 210015306 UKALL2014
210034492 210008377 1.66 67 Curative (C) 2016-08-09 2016-12-28 UKALL14- Cons Cycle 1 2 N 210015308 UKALL2014
210034493 210008381 1.78 75 Curative (C) 2015-06-18 2016-12-17 UKALL14- Intens/CNS Proph Y N 210015310 UKALL2014
210034495 210008395 1.76 86.1 Curative (C) 2015-04-12 2015-05-24 UKALL 14 TRIAL Y N 210015323 UKALL2014
210034497 210008410 1.54 53 Curative (C) 2016-06-09 2016-06-21 UKALL 14 TRIAL N N 210015346 UKALL2014
210034498 210008423 1.89 60.5 Curative (C) 2014-06-17 2015-12-12 UKALL14- Maintenance Y null 210015414 UKALL2014
210034499 210008429 1.83 101.7 Curative (C) 2010-11-18 2013-09-27 UKALL14- Intens/CNS Proph N null 210015423 UKALL2014
210034500 210008433 1.68 106.499 Curative (C) 2015-04-03 2015-04-03 UKALL14- Intens/CNS Proph Y null 210015424 UKALL2014
210034501 210008447 1.73 59.4 Curative (C) 2016-04-07 2016-04-26 UKALL 14 TRIAL null N 210015447 UKALL2014
210034502 210008450 1.6 49.4 Curative (C) 2016-04-01 2016-09-01 UKALL 14 TRIAL null N 210015451 UKALL2014
210034503 210008454 null 99.4 Curative (C) 2012-06-25 2014-01-07 UKALL14- Maintenance + Imatinib Y null 210015455 UKALL2014
210034504 210008459 null 143.8 Curative (C) 2013-04-12 2013-08-21 UKALL14- Intens/CNS Proph Y N 210015471 UKALL2014
210034505 210008465 1.74 94.499 Curative (C) 2015-11-01 2016-05-13 UKALL14- Maintenance Y null 210015472 UKALL2014
210034506 210019371 1.64 60.1 Curative (C) 2016-03-12 2016-10-22 UKALL14- Ph 2 Induction N N 210015487 UKALL2014
210034507 210008481 1.45 80 Curative (C) 2015-09-27 2016-01-03 UKALL14- Intens/CNS Proph N null 210015510 UKALL2014
210034508 210008493 1.82 75.3 Curative (C) 2019-03-08 2019-05-31 UKALL14- FMC (2 day) Conditioning Y N 210015534 UKALL2014
210034509 210008496 1.57 67.8 Curative (C) 2018-04-14 2018-04-14 UKALL14- Cons Cycle 2 N null 210015535 UKALL2014
210034510 210008505 1.64 56 Curative (C) 2017-03-11 2018-03-06 UKALL14- Cons Cycle 3 01 N 210015563 UKALL2014
210034511 210008509 1.87 95.799 Curative (C) 2016-05-12 2016-09-14 UKALL14- Cons Cycle 2 N N 210015569 UKALL2014
210034512 210008512 1.74 83 Curative (C) 2016-03-05 2016-11-09 UKALL14- Cons Cycle 3 N N 210015575 UKALL2014
210034513 210008515 1.55 60.8 Curative (C) 2016-07-24 2017-05-09 UKALL14- Ph 2 Induction 01 N 210015606 UKALL2014
210034514 210008519 1.57 36 Curative (C) 2013-12-06 2014-02-02 UKALL 14 TRIAL 1 N 210015612 UKALL2014
210034515 210008524 1.76 74.2 Curative (C) 2017-06-04 2017-12-15 UKALL14- Maintenance N N 210015620 UKALL2014
210034516 210026432 1.73 91.9 Curative (C) 2016-01-04 2016-07-16 UKALL14- Cons Cycle 3 N N 210015630 UKALL2014
210034517 210008532 1.75 79.4 Curative (C) 2016-04-18 2017-04-01 UKALL14- Maintenance N null 210015631 UKALL2014
210034518 210008539 1.65 63.1 Curative (C) 2015-12-18 2016-10-06 UKALL14- Ph 2 Induction + Imatinib 01 N 210015667 UKALL2014
210034519 210026436 1.75 64 Curative (C) 2014-01-28 2014-06-23 UKALL14- Maintenance Y null 210015675 UKALL2014
210034520 210037393 1.72 null Curative (C) 2017-09-21 2017-09-25 UKALL14- Maintenance null N 210015677 UKALL2014